Company Overview and News
(Bloomberg) -- Oil advanced amid growing international outrage over the disappearance of a prominent Saudi Arabian critics that put relations between the U.S. and kingdom on a knife edge.
UBS OXY ULSGF
HOUSTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Occidental Petroleum Corporation (NYSE:OXY) today confirmed it will no longer pursue the extension of the Idd El-Sharghi North Dome (ISND) offshore field in Qatar, which expires in October 2019.
2018-10-15 zacks - 1
Kinder Morgan Inc (KMI - Free Report) is expected to post third-quarter 2018 results on Oct 17. In the last reported quarter, the company delivered positive earnings surprise of 10.5%. Moreover, the company has pulled off an average positive earnings surprise of 9.8% in the last four quarters. Let’s see how things are shaping up prior to the announcement.
COP KMI OXY KMR KMRFZ CVB EOG
Laredo Petroleum is facing oil price related problems which will hurt its realizations that are forecasted to drop to 83% of WTI in Q3-2018 from well over 90% previously.
CHKVP PXD RDSB RDSA CHKDH CHKVZ CHKDG CHKDJ CHKDP CME RYDAF JAG CKRGZ RDS.B RDS.A CHKWZ 7018 CHK.WI CHK LPI RYDBF TRI OXY FANG
2018-10-12 seekingalpha - 1
There are plenty of media pundits ready with plausible explanations after every market sell-off, but if they really understood the causes, why'd they wait until after the sell-off to explain?
EA AKRX LULU OXY
Healthier oil and natural gas prices have made the Energy sector an attractive investment opportunity. Our latest Earnings Trends shows that Energy will lead all Zacks Sectors to witness the strongest earnings growth in Q3.
CBSH CBSHP WLL HES RRL RRS CBCB RGRLF COP RRC RGRYY OXY
HOUSTON (Reuters) - Corporations around the world should work together to reduce carbon emissions and stem climate change rather than wait for government mandates, the chief executive of U.S. oil producer Occidental Petroleum Corp said on Wednesday.
HOUSTON, Oct 10 (Reuters) - Corporations around the world should work together to reduce carbon emissions and stem climate change rather than wait for government mandates, the chief executive of U.S. oil producer Occidental Petroleum Corp said on Wednesday.
Crude oil was trading right around $74 a barrel early on Wednesday. Over the past month, crude has been up and down, reaching as high as about $77 and as low as $67, but the current crude price still pales in comparison to what it was in 2014.
COP BP XOM CVX BP BPAQF OXY PBR BP.A BP.B
This is the sixth month I have officially tracked dividend income (in an article) for John's Traditional and Roth IRA Accounts. His dividend income totaled $1,166.72.
POR CAT HTA RF LTC OPRF WMT KMI OMI WELL CBRL KMR CVB ABBV BBT DUKH GD NYSE MAIN KMB CLDT WPC ABBV OXY BA PK SCG HRNNF TD VLY CONE BOE MSCA SCU TD VTR RDS.A H TNTTF O PACW DUK MSCA.CL SCHW PEP CVX KMRFZ
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to OXY / Occidental Petroleum Corp. on message board site Silicon Investor.
as of ET